by Caroline Cassels 1/28/16
New Orally Disintegrating Tablet for ADHD in Kids
The US Food and Drug Administration (FDA) has approved an amphetamine extended-release orally disintegrating tablet (Adzenys XR-ODT) for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children aged 6 years and older. According to the drug company, Neos Therapeutics, the drug “is the first and only extended-release orally disintegrating tablet (ODT) for the treatment of ADHD.”
This drug is the bioequivalent of a previously approved mixed amphetamine salts extended-release capsule (Adderall XR, Shire), one of the most commonly prescribed medications for the treatment of ADHD.
According to Dr. Harold Levinson, this orally disintegrating tablet has several advantages: it’s rapidly absorbed, can be easily and accurately subdivided into smaller dose trials, and avoids problems with those ADHD individuals having difficulty swallowing.
About Dr. Harold Levinson
Formerly Clinical Associate Professor of Psychiatry at New York University Medical Center, Dr. Harold Levinson is currently Director of the Levinson Medical Center for Learning Disabilities in Long Island, New York. He is a well-known neuropsychiatrist, clinical researcher and author. For more information, call 1(800)334-7323 or
Image Courtesy of jk1991 FreeDigitalPhotos.net